To determine if MYC signaling is correlated with specific immune cell types, which might impact response to anti-PD-L1, we derived a MYC gene signature specific to breast cancer using published gene expression data from multiple MYC-driven mouse models of breast cancer. The gene discussed is MYC; the disease is breast carcinoma.